biomodal Revenue and Competitors

Cambridge, UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • biomodal's estimated annual revenue is currently $22.3M per year.(i)
  • biomodal's estimated revenue per employee is $155,000

Employee Data

  • biomodal has 144 Employees.(i)
  • biomodal grew their employee count by 23% last year.

biomodal's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
SVP Research and DevelopmentReveal Email/Phone
4
Head ITReveal Email/Phone
5
Head Intellectual PropertyReveal Email/Phone
6
Head Digital MarketingReveal Email/Phone
7
Director Product MarketingReveal Email/Phone
8
Associate Director Scientific AffairsReveal Email/Phone
9
Associate Director Product DevelopmentReveal Email/Phone
10
Associate Director Data ScienceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35-12%N/AN/A
#2
$16.3M1054%N/AN/A
#3
$107.2M49425%$292MN/A
#4
$2.6M83030%$631.7MN/A
#5
$18.1M117-8%$81MN/A
#6
$1.2M27112%$440MN/A
#7
$54.6M2820%$132.9MN/A
#8
$9.3M60-37%N/AN/A
#9
$21.2M13712%N/AN/A
#10
$408.2M164611%£994.6MN/A
Add Company

What Is biomodal?

biomodal is an omics based life-sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus. Our duet multiomics solution enables more epigenetic information from a single, low input DNA library without complex, resource intensive bioinformatics or harsh chemical treatment. Our single-base-resolution, phased sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer, neurodegenerative disease, and ageing.

keywords:N/A

N/A

Total Funding

144

Number of Employees

$22.3M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$33.3M1445%N/A
#2
$16.3M1458%N/A
#3
$28.7M14520%N/A
#4
$22.5M14528%$36M
#5
$3.5M14624%N/A